Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial.
about
Atherosclerosis and infection: is the jury still not in?Risk factors in coronary atherosclerosis athero-inflammation: the meeting pointMacrolide antibiotics and the risk of cardiac arrhythmiasCell wall-deficient bacteria as a cause of infections: a review of the clinical significance.Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trialCardiac risks associated with antibiotics: azithromycin and levofloxacinMacrolide antibiotics: current and future uses.Chlamydia pneumoniae and coronary artery disease: legitimized linkages?Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials.Antibiotic trials for coronary heart disease.Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients?Advances in the management of Chlamydia pneumoniae infections.Use of macrolides and tetracyclines for chronic inflammatory diseases.Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.Development potential of rifalazil and other benzoxazinorifamycins.Atherogenesis: the role of inflammation and infection.Chlamydophila pneumoniae infection and cardiovascular diseasePneumococcal vaccination and risk of myocardial infarction.Acute respiratory tract infections: a potential trigger for the acute coronary syndrome.A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseasesGuidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J miceChlamydia pneumoniae and progression of subclinical atherosclerosis.Chronic perivascular inoculation with Chlamydophila pneumoniae results in plaque formation in vivo.Update of antibiotic trials for secondary prevention of coronary heart disease.Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.Cardiovascular events and safety outcomes associated with azithromycin therapy: a meta-analysis of randomized controlled trials.The immune system in atherosclerosis and in acute myocardial infarction.Increased risk of mortality following antibiotic treatment in patients with coronary artery disease?The cardiovascular risk of azithromycin was increased in a large observational cohort study, contradicting findings from prior randomised trials.Potential Anti-Inflammatory Treatment of Ischemic Heart Disease.The Impact on Coronary Artery Disease of Common Polymorphisms Known to Modulate Responses to Pathogens
P2860
Q22241306-9899B48D-E832-42E3-98AB-CFC9637D056FQ24793107-7211A7AB-C984-4A13-8114-A2E80F06569BQ33772270-4ADEC358-B861-4DDE-96FE-305BC21FE252Q33984369-EB39BD06-EA6C-4D2E-9097-A2017A3F8577Q34248742-BF2A7479-CAA5-4B32-BEE5-E18DF17154E8Q35502601-F452256C-C4A2-4B60-82D8-D8EF6AACF04AQ35688156-B5E533FB-5A38-422E-9D35-2A3DFFBF3C21Q35696285-0D75EB80-2830-4E97-B6C4-39646927120FQ35709736-DD48759D-62B1-4DA2-A19A-1CD50917172DQ35733945-49B92A08-EB3B-495B-9AD5-6EFEC5A8FB62Q35758705-E9922AFC-D78C-4B26-AAD0-BF56663ADBDBQ35917262-25AE3EF2-A47D-4291-AA63-F803C44ACFFCQ35962028-67C62795-3888-4F1E-9A8C-D7A0AE5D1494Q36342810-AD4924A0-3E06-4929-B24C-F4DFC7476817Q36491823-8E03B62D-9914-45B3-88E8-570ADC8F276CQ36774193-112D326B-3F48-4AFD-A9CF-3AA08CC0AC79Q36783331-976E2E68-0169-4244-9F62-833D918FB502Q36909937-14D84513-1FCD-48FA-960B-E2B156E79A58Q37091874-BD299CC3-890A-42C1-8BC8-0A48EFDB8897Q37098266-911AB8F9-2309-4004-894F-1B61E6E210C9Q37251490-1C2EFFA6-66D2-4E82-890B-0DAD2EE6C53DQ37568474-2FE6E6EC-5C63-45B5-8791-DB5476FBFF3AQ37847433-3F6F8D47-7C2B-4A98-A763-33A9B4A4E39EQ37862676-23D0FFE1-FAD2-48D5-9DFC-7FDE054F9F59Q37865389-E3E6A73E-04A2-46DF-BF3C-DA77267AF321Q38211000-58EC0A75-0988-4140-87BC-10B667364DA9Q38307119-5B6BC78F-90AC-4427-B9CB-ABDA426E9F7AQ38605504-030A7728-386C-4A4E-8A3F-80978C07415EQ43474237-C55BB371-79CB-4DB5-871E-D8A094DCF1A2Q43505291-3876148A-4FA2-42A6-A32A-D2F99420B8A1Q53824658-61C02CFE-B91C-4884-9BD8-A536E39B3ED2Q57315909-8F652BEE-437F-427A-945A-0EBE4E507C66
P2860
Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2003
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of short-term treatment ...... a randomised controlled trial.
@en
Effect of short-term treatment ...... cin in Acute Coronary Syndrome
@nl
type
label
Effect of short-term treatment ...... a randomised controlled trial.
@en
Effect of short-term treatment ...... cin in Acute Coronary Syndrome
@nl
prefLabel
Effect of short-term treatment ...... a randomised controlled trial.
@en
Effect of short-term treatment ...... cin in Acute Coronary Syndrome
@nl
P2093
P1433
P1476
Effect of short-term treatment ...... a randomised controlled trial.
@en
P2093
AZACS Investigators
Bojan Cercek
Doron Zahger
Gerald Maurer
Peter Mahrer
Prediman K Shah
Shlomi Matetzky
Uwe Zeymer
P304
P356
10.1016/S0140-6736(03)12706-7
P407
P577
2003-03-01T00:00:00Z